Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.

Expected to kick off in 2018, the Fan-Controlled Football League (FCFL) reimagines American football – and the experience of being a die-hard fan – for the digital age. The FCFL will seek to deliver a compelling football product that captivates a broader digital audience. It will feature fast-paced, high-scoring action that embraces the spread-football evolution of the NCAA football and NFL games while enabling a diverse set of styles and strategies on both offense and defense ─ all controlled by the fans. Player personnel and real-time play calling decisions are all made by fans via the league’s blockchain platform, making fans the coach and general manager for their team. Fans will no longer be just viewers; rather, they will be active contributors to the games they are watching. This is a transformational shift in the way sports fans engage and interact: no more sitting back and passively watching as a team’s roster takes shape or a game unfolds. They will be essential to the league’s product both on the field and off. This is the democratization of sports, and it’s about to be realized through the most innovative sports league ever created, thanks to decentralized blockchain technology.

At its core, Nice 1 is a blockchain game development platform. When using Nice 1, a game developer can raise funds from public and private supporters. However, Nice 1 goes further than just mere fundraising. The Nice 1 blockchain provides users with access to an SDK library (and documentation) for Unreal Engine & Unity. Nice 1 is striving to create state-of-the-art gaming services for streamers and esports enthusiasts. Non-game developers can earn and support gamers and developers, by helping support the Nice 1 blockchain network. The primary goal of Nice 1, is to promote innovation in gaming worldwide. However, in the process, Nice 1 is also striving to tackle increasing censorship in gaming.

Co-DEX is a Decentralized trading platform for cryptocurrencies, built on vanguard security infrastructure and using a revolutionary system. Co-DEX is an exchange created by the community, for the community, thus Co-DEX will be the first exchange that will apply a NO FEES policy on transactions, the users being required to cover solely the transaction cost of the miners and/or validators that register the action on the blockchains. Experience direct peer-to-peer trading without the security risk of trusting a third party, thus having complete control of your assets at any time.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.